HRT Class Labeling Should Not Cover Topical Estrogens, Pharmacia Says
Executive Summary
Topical hormone therapy drugs should be exempt from FDA's proposed estrogen class labeling incorporating safety information from the Women's Health Initiative study, Pharmacia maintained in comments submitted to the agency